logo

For the Inventor, By the Inventor

Gaithersburg, MD, United States of America

Sequoia Pharmaceuticals, Inc.


USPTO Granted Patents = 20

% Expired Patents = 90.0



Forward Citations = 47

Loading Chart...
Loading Chart...

14 inventors (with patents filed for the assignee):

goldMedal Michael Eissenstat (19 out of 26 patents)

silverMedal Dehui Duan (12 out of 12 patents)

bronzeMedal John W Erickson (4 out of 20 patents)

4.  Ji-Hye Kang (3 out of 3 patents)

5.  Andrey Topin (2 out of 2 patents)

6.  Greg Delahanty (2 out of 2 patents)

7.  Gnana Ravi Rajendran (2 out of 2 patents)

8.  Abelardo Silva (2 out of 3 patents)

9.  Pavel Majer (1 out of 27 patents)

10.  Sergei V Gulnik (1 out of 6 patents)

11.  Jihye Kang (1 out of 1 patent)

12.  Sergi Gulnik (1 out of 1 patent)

13.  Rongjuan Lu (1 out of 1 patent)

14.  Tatiana Guerassina (1 out of 1 patent)


20 patents:

1. 9849107 - Compositions and methods for inhibiting cytochrome P450 (2017-12-26),
2. 9604952 - Compositions and methods for inhibiting cytochrome P450 2D6 (2017-03-28),
3. 9540354 - Diamide inhibitors of cytochrome P450 (2017-01-10),
4. 9403789 - Benzofuran-containing amino acid inhibitors of cytochrome P450 (2016-08-02),
5. 9233952 - Compositions and methods for inhibiting cytochrome P450 (2016-01-12),
6. 8952056 - Methods for inhibiting drug degradation (2015-02-10),
7. 8906647 - Diamide inhibitors of cytochrome P450 (2014-12-09),
8. 8791157 - 5-substituted benzofurans as inhibitors of cytochrome P450 2D6 (2014-07-29),
9. 8703700 - Bimacrocylic HCV NS3 protease inhibitors (2014-04-22),
10. 8673970 - HIV protease inhibitor and cytochrome p450 inhibitor combinations (2014-03-18),
11. 8569364 - 5-substituted benzofurans as inhibitors of cytochrome P450 2D6 (2013-10-29),
12. 8481520 - Compositions and methods for inhibiting cytochrome P450 (2013-07-09),
13. 8389571 - Benzofuran derived HIV protease inhibitors (2013-03-05),
14. 8048871 - Compositions and methods for inhibiting cytochrome P450 (2011-11-01),
15. 7981929 - Benzofuran derived HIV protease inhibitors (2011-07-19),
Company Overview
Sequoia Pharmaceuticals, Inc. is a biopharmaceutical company based in Gaithersburg, Maryland, specializing in the development of innovative therapies for various diseases. The organization focuses on advancing drug discovery and development processes, particularly in the fields of oncology and infectious diseases. By leveraging cutting-edge research and technology, Sequoia aims to address unmet medical needs and improve patient outcomes through its pipeline of novel therapeutic candidates.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

20 Patents

#20 in Gaithersburg, MD

#216 in Maryland

#16,395 in US

#31,264 in the World

Gaithersburg, MD (US)
Gaithersburg, MD, United States of America

Sequoia Pharmaceuticals, Inc.

Forward Citations = 47

14 inventors:

goldMedal Michael Eissenstat (19 out of 26 patents)

silverMedal Dehui Duan (12 out of 12 patents)

bronzeMedal John W Erickson (4 out of 20 patents)

4.  Ji-Hye Kang (3 out of 3 patents)

5.  Andrey Topin (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Sequoia Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/sequoia-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…